122 related articles for article (PubMed ID: 12932905)
1. Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates.
Furin A; Guiotto A; Baccichetti F; Pasut G; Deuschel C; Bertani R; Veronese FM
Eur J Med Chem; 2003; 38(7-8):739-49. PubMed ID: 12932905
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2].
Shamsuddin S; Santillan CC; Stark JL; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 1998 Aug; 71(1-2):29-35. PubMed ID: 9755489
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor activity [correction for activitiy] of trans(+/-)-1,2-diaminocyclo- hexaneglutamatoplatinum(II) formulated with stealth liposome.
Han I; Kim OJ; Lee GY; Sung YK; Song R; Sohn YS
Bioorg Med Chem; 2003 Dec; 11(24):5443-7. PubMed ID: 14642589
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
7. Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids.
Kim YS; Song R; Chung HC; Jun MJ; Sohn YS
J Inorg Biochem; 2004 Jan; 98(1):98-104. PubMed ID: 14659638
[TBL] [Abstract][Full Text] [Related]
8. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
Mauldin SK; Husain I; Sancar A; Chaney SG
Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of cyclotriphosphazene-(diamine)platinum(II) conjugates.
Baek H; Cho Y; Lee CO; Sohn YS
Anticancer Drugs; 2000 Oct; 11(9):715-25. PubMed ID: 11129734
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of riboflavin and flavin mononucleotide Pt(II) complexes.
Suzuki K; Noji M; Tashiro T; Kidani Y
Chem Pharm Bull (Tokyo); 1988 May; 36(5):1895-8. PubMed ID: 3203425
[No Abstract] [Full Text] [Related]
11. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
12. Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane.
Vollano JF; Al-Baker S; Dabrowiak JC; Schurig JE
J Med Chem; 1987 Apr; 30(4):716-9. PubMed ID: 3560163
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes.
Farrell N; Qu Y; Hacker MP
J Med Chem; 1990 Aug; 33(8):2179-84. PubMed ID: 2374143
[TBL] [Abstract][Full Text] [Related]
14. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes.
Khokhar AR; al-Baker S; Siddik ZH
J Inorg Biochem; 1994 Apr; 54(1):39-47. PubMed ID: 8151310
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
Pages BJ; Li F; Wormell P; Ang DL; Clegg JK; Kepert CJ; Spare LK; Danchaiwijit S; Aldrich-Wright JR
Dalton Trans; 2014 Nov; 43(41):15566-75. PubMed ID: 25197979
[TBL] [Abstract][Full Text] [Related]
17. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
Han I; Khokhar AR; Perez-Soler R
Cancer Chemother Pharmacol; 1996; 39(1-2):17-24. PubMed ID: 8995495
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.
Top S; Kaloun el B; Vessières A; Leclercq G; Laïos I; Ourevitch M; Deuschel C; McGlinchey MJ; Jaouen G
Chembiochem; 2003 Aug; 4(8):754-61. PubMed ID: 12898627
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
Gibbons GR; Kaufmann WK; Chaney SG
Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
[TBL] [Abstract][Full Text] [Related]
20. Role of carrier ligand in platinum resistance in L1210 cells.
Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG
Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]